Compare WVE & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | GCT |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | Singapore | United States |
| Employees | N/A | 1644 |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.8B |
| IPO Year | 2015 | 2021 |
| Metric | WVE | GCT |
|---|---|---|
| Price | $5.17 | $50.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 1 |
| Target Price | $29.81 | ★ $33.00 |
| AVG Volume (30 Days) | ★ 3.2M | 685.6K |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.70 |
| EPS | N/A | ★ 2.19 |
| Revenue | $3,704,000.00 | ★ $1,161,042,000.00 |
| Revenue This Year | N/A | $14.43 |
| Revenue Next Year | $85.67 | $6.78 |
| P/E Ratio | ★ N/A | $22.67 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $5.01 | $25.17 |
| 52 Week High | $21.73 | $56.27 |
| Indicator | WVE | GCT |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 61.33 |
| Support Level | $5.02 | $36.09 |
| Resistance Level | $6.39 | $51.82 |
| Average True Range (ATR) | 0.33 | 2.72 |
| MACD | -0.02 | -0.46 |
| Stochastic Oscillator | 12.50 | 46.34 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.